Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kenya-TES: AL and DHP for Uncomplicated Malaria
NCT04767191Phase 4Completed
- Sponsor
- Jhpiego
- Start
- Mar 2021
- Primary completion
- Dec 2022
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of artemether + lumefantrine, dihydroartemisinin + piperaquine in malaria, sponsored by Jhpiego. Started Mar 2021; status: completed.
02
Drugs
artemether + lumefantrinedihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04767191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04767191.